NEW YORK, NY, December 17, 2021 — Arbor Rapha Capital Bioholodings Corp. I (NASDAQ: ARCKU) (the “Company”) today announced that, commencing December 20, 2021, holders of the units sold in the Company’s...
Read More
Includes Exercise of Underwriters’ Over-Allotment Option in Full NEW YORK, NY, November 2, 2021 — Arbor Rapha Capital Bioholdings Corp. I (the “Company”) (NASDAQ: ARCKU) announced today the closing of...
Read More
SPAC season is back as Arbor Rapha Capital Bioholdings, a blank-check company, lands on the public markets today to raise $150 million for a future biopharma merger. By Kyle LaHucik | Oct 29, 2021 10:15am | FierceBiotech
NEW YORK, Oct. 28, 2021 /PRNewswire/ -- Arbor Rapha Capital Bioholdings Corp. I (the "Company") announced today that it priced its initial public offering of 15,000,000 units at $10.00 per unit. The units will be listed on The...
Read More